Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period (Q34818608)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period |
scientific article |
Statements
1 reference
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period (English)
1 reference
Gerd R Burmester
1 reference
Tom W J Huizinga
1 reference
Vivian P Bykerk
1 reference
Bernard G Combe
1 reference
Daniel E Furst
1 reference
Emilie Barré
1 reference
Chetan S Karyekar
1 reference
Dennis A Wong
1 reference
3 November 2014
1 reference
1 reference
74
1 reference
1
1 reference
19-26
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference